To include your compound in the COVID-19 Resource Center, submit it here.

Foscan temoporfin chlorin-based photodynamic therapy regulatory update

Following a meeting with the FDA, SOH said it will submit an amendment

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE